Molecular Regulation of Cushion Morphogenesis

Heart Development and Regeneration

Volumn , Issue , 2010, Pages 363-387

  Camenisch, Todd D ^a   Runyan, Raymond B ^b   Markwald, Roger R ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859445671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381332-9.00018-9     Document Type: Chapter

References (206)

1. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R.F., Aikawa M., Schoen F.J. Human semilunar cardiac valve remodeling by activated cells from fetus to adult - Implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344-1352.
2. Araki T., Mohi M.G., Ismat F.A., Bronson R.T., Williams I.R., Kutok J.L., Yang W.T., Pao L.I., Gilliland D.G., Epstein J.A., Neel B.G. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat. Med. 2004, 10:849-857.
3. Armstrong E.J., Bischoff J. Heart valve development - Endothelial cell signaling and differentiation. Circ. Res. 2004, 95:459-470.
4. Azhar M., Runyan R.B., Gard C., Sanford L.P., Miller M.L., Andringa A., Pawlowski S., Rajan S., Doetschman T. Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development. Dev. Dyn. 2009, 238:431-442.
5. Azhar M., Schultz Jel J., Grupp I., Dorn G.W., Meneton P., Molin D.G., Gittenberger-de Groot A.C., Doetschman T. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 2003, 14:391-407.
6. Baladron V., Ruiz-Hidalgo M.J., Nueda M.L., Diaz-Guerra M.J., Garcia-Ramirez J.J., Bonvini E., Gubina E., Laborda J. Dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp. Cell Res. 2005, 303:343-359.
7. Baldwin H.S., Solursh M. Degradation of hyaluronic acid does not prevent looping of the mammalian heart in situ. Dev. Biol. 1990, 136(2):555-559.
8. Baldwin H.S., Shen H.M., Yan H.C., DeLisser H.M., Chung A., Mickanin C., Trask T., Kirschbaum N.E., Newman P.J., Albelda S.M. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31), alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 1994, 120(9):2539-2553.
9. Bartram U., Bartelings M.M., Kramer H.H., Gittenberger-de Groot A.C. Congenital polyvalvular disease: A review. Pediatr. Cardiol. 2001, 22:93-101.
10. Bartram U., Molin D.G., Wisse L.J., Mohamad A., Sanford L.P., Doetschman T., Speer C.P., Poelmann R.E., Gittenberger-De Groot A.C. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in tgf-beta (2)-knockout mice. Circulation 2001, 103:2745-2752.
11. Bashey R.I., Martinez-Hernandez A., Jimenez S.A. Isolation, characterization, and localization of cardiac collagen type VI. Associations with other extracellular matrix components. Circ. Res. 1992, 70:1006-1017.
12. Bernanke D.H., Markwald R.R. Effects of hyaluronic acid on cardiac cushion tissue cells in collagen matrix cultures. Tex. Rep. Biol. Med. 1979, 39:271-285.
13. Bernanke D.H., Orkin R.W. Hyaluronate binding and degradation by cultured embryonic chick cardiac cushion and myocardial cells. Dev. Biol. 1984, 106:360-367.
14. Bornstein P. Matricellular proteins, an overview: Introduction. Matrix Biol. 2000, 19:555-556.
15. Bouchey D., Argraves W.S., Little C.D. Fibulin-1, vitronectin, and fibronectin expression during avian cardiac valve and septa development. Anat. Rec. 1996, 244:540-551.
16. Boyer A.S., Runyan R.B. TGF beta type III and TGF beta type II receptors have distinct activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Dyn. 2001, 221:454-459.
17. Boyer A.S., Ayerinskas I.I., Vincent E.B., McKinney L.A., Weeks D.L., Runyan R.B. TGF beta 2 and TGF beta 3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Biol. 1999, 208:530-545.
18. Braverman A.C., Guven H., Beardslee M.A., Makan M., Kates A.M., Moon M.R. The bicuspid aortic valve. Curr. Problems Cardiol. 2005, 30:470-522.
19. Brown C.B., Boyer A.S., Runyan R.B., Barnett J.V. Antibodies to the type II TGF beta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev. Biol. 1996, 174:248-257.
20. Brown C.B., Boyer A.S., Runyan R.B., Barnett J.V. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 1999, 283:2080-2082.
21. Butcher J.T., Markwald R.R. Valvulogenesis, the moving target. Phil. Trans. Royal Soc. B. Biol. Sci. 2007, 362:1489-1503.
22. Butcher J.T., McQuinn T.C., Sedmera D., Turner D., Markwald R.R. Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ. Res. 2007, 100:1503-1511.
23. Butcher J.T., Norris R.A., Hoffman S., Mjaatvedt C.H., Markwald R.R. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev. Biol. 2007, 302:256-266.
24. Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A., Kubalak S., Klewer S.E., McDonald J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 2000, 106:349-360.
25. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-de Groot A.C., McDonald J.A., Klewer S.E. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 2002, 248:170-181.
26. Camenisch T.D., Schroeder J.A., Bradley J., Klewer S.E., McDonald J.A. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat. Med. 2002, 8:850-855.
27. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
28. Carvalhaes L.S., Gervasio O.L., Guatimosim C., Heljasvaara R., Sormunen R., Pihlajaniemi T., Kitten G.T. Collagen XVIII/endostatin is associated with the epithelial-mesenchymal transformation in the atrioventricular valves during cardiac development. Dev. Dyn. 2006, 235:132-142.
29. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell 2004, 118:649-663.
30. Chang H., Huylebroech D., Verschueren K., Guo Q., Matzuk M.M., Zwijsen A. Smad5 knockout mice die at midgestation due to multiple embryonic and extraembryonic defects. Development 1999, 126:1631-1642.
31. Chen B., Bronson R.T., Klaman L.D., Hampton T.G., Wang J.F., Green P.J., Magnuson T., Douglas P.S., Morgan J.P., Neel B.G. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat. Genet. 2000, 24:296-299.
32. Chen Q., Chen H., Zheng D., Kuang C., Fang H., Zou B., Zhu W., Bu G., Jin T., Wang Z., Zhang X., Chen J., Field L.J., Rubart M., Shou W., Chen Y. Smad7 is required for the development and function of the heart. J. Biol. Chem. 2009, 284:292-300.
33. Cole W.G., Chan D., Hickey A.J., Wilcken D.E. Collagen composition of normal and myxomatous human mitral heart-valves. Biochem. J. 1984, 219:451-460.
34. de Caestecker M. The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev. 2004, 15:1-11.
35. de la Cruz M.V., Markwald R.R. Embryological development of the ventricular inlets. Septation and atrioventricular valve apparatus. Living Morphogenesis of the Heart 1998, 131-157. Birkhauser, Boston, MA. R.R. Markwald (Ed.).
36. de Lange F.J., Moorman A.F., Anderson R.H., Manner J., Soufan A.T., de Vries C.D., Schneider M.D., Webb S., van den Hoff M.J., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 2004, 95:645-654.
37. Delot E.C., Bahamonde M.E., Zhao M., Lyons K.M. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 2003, 130:209-220.
38. DeSesso J.M. Maternal factors in developmental toxicity. Teratog. Carcinog. Mutagen. 1987, 7:225-240.
39. Desgrosellier J.S., Mundell N.A., McDonnell M.A., Moses H.L., Barnett J.V. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev. Biol. 2005, 280:201-210.
40. Dickson M.C., Slager H.G., Duffie E., Mummery C.L., Akhurst R.J. RNA and protein localisations of TGF beta 2 in the early mouse embryo suggest an involvement in cardiac development. Development 1993, 117:625-639.
41. Dietz H.C., Loeys B., Carta L., Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am. J. Med. Genet. (Part C: Semin. Med. Genet.) 2005, 139C:4-9.
42. Dor Y., Klewer S.E., McDonald J.A., Keshet E., Camenisch T.D. VEGF modulates early heart valve formation. Anat. Rec. 2003, 271A:202-208.
43. Dunker N., Krieglstein K. Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis. Eur. J. Biochem. 2000, 267:6982-6988.
44. Eisenberg L.M., Markwald R.R. Cellular recruitment and the development of the myocardium. Dev. Biol. 2004, 274:225-232.
45. Enciso J.M., Gratzinger D., Camenisch T.D., Canosa S., Pinter E., Madri J.A. Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation, modulation by PECAM-1 and MMP-2. J. Cell Biol. 2003, 160:605-615.
46. Fallon J.F., Lopez A., Ros M.A., Savage M.P., Olwin B.B., Simandl B.K. Fgf-2-apical ectodermal ridge growth signal for chick limb development. Science 1994, 264:104-107.
47. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
48. Filip D.A., Radu A., Simionescu M. Interstitial-cells of the heart-valves possess characteristics similar to smooth-muscle cells. Circ. Res. 1986, 59:310-320.
49. Forouhar A.S., Liebling M., Hickerson A., Nasiraei-Moghaddam A., Tsai H.J., Hove J.R., Fraser S.E., Dickinson M.E., Gharib M. The embryonic vertebrate heart tube is a dynamic suction pump. Science 2006, 312:751-753.
50. Francis-West P.H., Tatla T., Brickell P.M. Expression patterns of the bone morphogenetic protein genes Bmp-4 and Bmp-2 in the developing chick face suggest a role in outgrowth of the primordia. Dev. Dyn. 1994, 201:168-178.
51. Galvin K.M., Donovan M.J., Lynch C.A., Meyer R.I., Paul R.J., Lorenz J.N., Fairchild-Huntress V., Dixon K.L., Dunmore J.H., Gimbrone M.A., Falb D., Huszar D. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 2000, 24:171-174.
52. Garg V. Molecular genetics of aortic valve disease. Curr. Opin. Cardiol. 2006, 21:180-184.
53. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
54. Gaussin V., Van de Putte T., Mishina Y., Hanks M.C., Zwijsen A., Huylebroeck D., Behringer R.R., Schneider M.D. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2878-2883.
55. Gaussin V., Morley G.E., Cox L., Zwijsen A., Vance K.M., Emile L., Tian Y.M., Liu J., Hong C., Myers D., Conway S.J., Depre C., Mishina Y., Behringer R.R., Hanks M.C., Schneider M.D., Huylebroeck D., Fishman G.I., Burch J.B., Vatner S.F. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ. Res. 2005, 97:219-226.
56. Gittenberger-de Groot A.C., Vrancken Peeters M.P., Mentink M.M., Gourdie R.G., Poelmann R.E. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 1998, 82:1043-1052.
57. Goumans M.J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 2002, 21:1743-1753.
58. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolós V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., Shou W., Ballestar E., Esteller M., Rojas A., Pérez-Pomares J.M., de la Pompa J.L. Notch signaling is essential for ventricular chamber development. Dev. Cell 2007, 12:415-429.
59. Habashi J.P., Judge D.P., Holm T.M., Cohn R.D., Loeys B.L., Cooper T.K., Myers L., Klein E.C., Liu G.S., Calvi C., Podowski M., Neptune E.R., Halushka M.K., Bedja D., Gabrielson K., Rifkin D.B., Carta L., Ramirez F., Huso D.L., Dietz H.C. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006, 312:117-121.
60. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
61. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ. Res. 2006, 98:1431-1438.
62. Hoffmann A., Preobrazhenska O., Wodarczyk C., Medler Y., Winkel A., Shahab S., Huylebroeck D., Gross G., Verschueren K. Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors. J. Biol. Chem. 2005, 280:27271-27283.
63. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002, 39:1890-1900.
64. Hogan B.L. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 1996, 6:432-438.
65. Honda A., Kanke Y., Mori Y. Biochemical study of cardiac valvular tissue - isolation of glycoproteins and proteoglycans from salt-insoluble materials of bovine heart valve. J. Mol. Cell Cardiol. 1975, 7:715-732.
66. Horiuchi K., Amizuka N., Takeshita S., Takamatsu H., Katsuura M., Ozawa H., Toyama Y., Bonewald L.F., Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Min. Res. 1999, 14:1239-1249.
67. Icardo J.M., Colvee E. Atrioventricular valves of the mouse. 3. Collagenous skeleton and myotendinous junction. Anat. Rec. 1995, 243:367-375.
68. Iekushi K., Taniyama Y., Azuma J., Katsuragi N., Dosaka N., Sanada F., Koibuchi N., Nagao K., Ogihara T., Morishita R. Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension 2007, 49:1409-1414.
69. Isner J.M., Ropper A., Hirst K. VEGF gene transfer for diabetic neuropathy. Hum. Gene. Ther. 2001, 12:1593-1594.
70. Iwamoto R., Yamazaki S., Asakura M., Takashima S., Hasuwa H., Miyado K., Adachi S., Kitakaze M., Hashimoto K., Raab G., Nanba D., Higashiyama S., Hori M., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3221-3226.
71. Jackson L.F., Qiu T.H., Sunnarborg S.W., Chang A., Zhang C.L., Patterson C., Lee D.C. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 2003, 22:2704-2716.
72. Jiao K., Langworthy M., Batts L., Brown C.B., Moses H.L., Baldwin H.S. Tgf beta signaling is required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development. Development 2006, 133:4585-4593.
73. Johnson D.W., Berg J.N., Baldwin M.A., Gallione C.J., Marondel I., Yoon S.-J., Stenzel T.T, Speer M., Pericak-Vance M.A., Diamond A., Guttmacher A.E., Jackson C.E., Attisano L., Kucherlapati R., Porteous M.E., Marchuk D.A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 1996, 13:189-195.
74. Johnson E.N., Lee Y.M., Sander T.L., Rabkin E., Schoen F.J., Kaushal S., Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J. Biol. Chem. 2003, 278:1686-1692.
75. Johnson G.L., Dohlman H.G., Graves L.M. MAPK kinase kinases (MKKKs) as a target class for small-molecule inhibition to modulate signaling networks and gene expression. Curr. Opin. Chem. Biol. 2005, 9:325-331.
76. Jones C.M., Lyons K.M., Hogan B.L. Involvement of bone morphogenetic protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991, 111:531-542.
77. Kaartinen V., Voncken J.W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 1995, 11:415-421.
78. Kaartinen V., Haataja L., Nagy A., Heisterkamp N., Groffen J. TGF beta 3-induced activation of RhoA/Rho-kinase pathway is necessary but not sufficient for epithelio-mesenchymal transdifferentiation, Implications for palatogenesis. Int. J. Mol. Med. 2002, 9:563-570.
79. Kahler R.A., Westendorf J.J. Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. J. Biol. Chem. 2003, 278:11937-11944.
80. Kern C.B., Hoffman S., Moreno R., Damon B.J., Norris R.A., Krug E.L., Markwald R.R., Mjaatvedt C.H. Immunolocalization of chick periostin protein in the developing heart. Anat. Rec. (Part A - Discoveries in Mol. Cell. and Evol. Biol.) 2005, 284A:415-423.
81. Kern C.B., Twal W.O., Mjaatvedt C.H., Fairey S.E., Toole B.P., Iruela-Arispe M.L., Argraves W.S. Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev. Dyn. 2006, 235:2238-2247.
82. Kinsella M., Fitzharris T. Origin of cushion tissue in the developing chick heart, cinematographic recordings of in situ formation. Science 1980, 207:1359-1360.
83. Kitten G.T., Markwald R.R., Bolender D.L. Distribution of basement membrane antigens in cry preserved early embryonic hearts. Anat. Rec. 1987, 217(4):379-390.
84. Klewer S.E., Krob S.L., Kolker S.J., Kitten G.T. Expression of type VI collagen in the developing mouse heart. Dev. Dyn. 1998, 211:248-255.
85. Klewer S.E., Yatskievych T., Pogreba K., Stevens M.V., Antin P.B., Camenisch T.D. Has2 expression in heart forming regions is independent of BMP signaling. Gene. Expr. Patterns 2006, 6:462-470.
86. Kolditz D., Wijffels M., Blom N., van der Laarse A., Markwald R., Schalij M., Gittenberger-de Groot A.C. Persistence of functional atrioventricular accessory pathways in post-septated embryonic avian hearts, implications for morphogenesis and functional maturation of the cardiac conduction system. Circ. Res. 2007, 115:17-26.
87. Krug E.L., Runyan R.B., Markwald R.R. Protein extracts from early embryonic hearts initiate cardiac endothelial cytodifferentiation. Dev. Biol. 1985, 112(2):414-426.
88. Kruithof B.P., Krawitz S.A., Gaussin V. Atrioventricular valve development during late embryonic and postnatal stages involves condensation and extracellular matrix remodeling. Dev. Biol. 2007, 302:208-217.
89. Kruzynska-Frejtag A., Machnicki M., Rogers R., Markwald R.R., Conway S.J. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech. Dev. 2001, 103:183-188.
90. Kyndt F., Gueffet J.P., Probst V., Jaafar P., Legendre A., Le Bouffant F., Toquet C., Roy E., McGregor L., Lynch S.A., Newbury-Ecob R., Tran V., Young I., Trochu J.N., Le Marec H., Schott J.J. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy. Circulation 2007, 115:40-49.
91. Lai E.C. Notch signaling, control of cell communication and cell fate. Development 2004, 131:965-973.
92. Lai Y.T., Beason K.B., Brames G.P., Desgrosellier J.S., Cleggett M.C., Shaw M.V., Brown C.B., Barnett J.V. Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation. Dev. Biol. 2000, 222:1-11.
93. Lakkis M.M., Epstein J.A. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 1998, 125:4359-4367.
94. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium, deleterious effects of unregulated expression. Circulation 2000, 102:898-901.
95. Lewandoski M., Sun X., Martin G.R. Fgf8 signaling from the AER is essential for normal limb development. Nat. Genet. 2000, 26:460-463.
96. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., Dejana E. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 2004, 166:359-367.
97. Lincoln J., Alfieri C.M., Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev. Dyn. 2004, 230:239-250.
98. Lincoln J., Alfieri C.M., Yutzey K.E. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev. Biol. 2006, 292:290-302.
99. Lindsley A., Li W., Wang J., Maeda N., Rogers R., Conway S.J. Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene. Expr. Patterns 2005, 5:593-600.
100. Litvin J., Zhu S.M., Norris R., Markwald R.R. Periostin family of proteins, therapeutic targets for heart disease. Anat. Rec. (Part a -Discoveries in Mol. Cellular and Evol. Biol.) 2005, 287A:1205-1212.
101. Loeber C.P., Runyan R.B. A comparison of fibronectin, laminin, and galactosyltransferase adhesion mechanisms during embryonic cardiac mesenchymal cell migration in vitro. Dev. Biol. 1990, 140(2):401-412.
102. Loomes K.M., Underkoffler L.A., Morabito J., Gottlieb S., Piccoli D.A., Spinner N.B., Baldwin H.S., Oakey R.J. The expression of Jagged1 in the developing mammalian heart correlates with cardiovascular disease in Alagille syndrome. Hum. Mol. Genet. 1999, 8:2443-2449.
103. Loomes K.M., Taichman D.B., Glover C.L., Williams P.T., Markowitz J.E., Piccoli D.A., Baldwin H.S., Oakey R.J. Characterization of Notch receptor expression in the developing mammalian heart and liver. Am. J. Med. Genet. 2002, 112:181-189.
104. Lopez-Casillas F., Cheifetz S., Doody J., Andres J.L., Lane W.S., Massagué J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991, 67:785-795.
105. Lopez-Casillas F., Payne H.M., Andres J.L., Massague J. Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors, mapping of ligand binding and GAG attachment sites. J. Cell Biol. 1994, 124:557-568.
106. Lueder F.L., Kim S.B., Buroker C.A., Bangalore S.A., Ogata E.S. Chronic maternal hypoxia retards fetal growth and increases glucose utilization of select fetal tissues in the rat. Metabolism 1995, 44:532-537.
107. Luetteke N.C., Phillips H.K., Qiu T.H., Copeland N.G., Earp H.S., Jenkins N.A., Lee D.C. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 1994, 8:399-413.
108. Lyons K.M., Pelton R.W., Hogan B.L. Organogenesis and pattern formation in the mouse, RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 1990, 109:833-844.
109. Ma L.J., Lu M.F., Schwartz R.J., Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
110. Manasek F.J., Reid M., Vinson W., Seyer J., Johnson R. Glycosaminoglycan synthesis by the early embryonic chick heart. Dev. Biol. (Orlando) 1973, 35:332-348.
111. Markwald R.R., Fitzharris T.P., Manasek F.J. Structural development of endocardial cushions. Am. J. Anat. 1977, 148:85-119.
112. Markwald R.R., Runyan R.B., Kitten G.T., Funderburg F.M., Bernanke D.H., Brauer P.R. Use of collagen gel cultures to study heart development, proteoglycan and glycoprotein interactions during formation of endocardial cushion tissue. The Role of Extracellular Matrix in Development 1984, 323-350. Alan R. Liss, Inc, New York, NY. R.L. Trelstad (Ed.).
113. Markwald R., Trusk T., Moreno-Rodriguez R. Formation and septation of the tubular heart, integrating the dynamics of morphology with emerging molecular concepts. Living Morphogenesis of the Heart 1998, 43-84. Birkhauser, Boston, MA. M. de la Cruz, R.R. Markwald (Eds.).
114. McAllister K.A., Grogg K.M., Johnson D.W., Gallione C.J., Baldwin M.A., Jackson C.E., Helmbold E.A., Markel D.S., Mckinnon W.C., Murrell J., Mccormick M.K., Pericakvance M.A., Heutink P., Oostra B.A., Haitjema T., Westerman C.J., Porteous M.E., Guttmacher A.E., Letarte M., Marchuk D.A. Endoglin, a Tgf-Beta binding-protein of endothelial-cells, is the gene for hereditary hemorrhagic telangiectasia type-1. Nat. Genet. 1994, 8:345-351.
115. McCright B., Gao X., Shen L.Y., Lozier J., Lan Y., Maguire M., Herzlinger D., Weinmaster G., Jiang R.L., Gridley T. Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation. Development 2001, 128:491-502.
116. McCright B., Lozier J., Gridley T. A mouse model of Alagille syndrome, Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development 2002, 129:1075-1082.
117. McGuire P.G., Orkin R.W. Urokinase activity in the developing avian heart, aspatial and temporal analysis. Dev. Dyn. 1992, 193:24-33.
118. Meng K., Rodriguez-Pena A., Dimitrov T., Chen W., Yamin M., Noda M., Deuel T.F. Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Nat. Acad. Sci. U.S.A. 2000, 97:2603-2608.
119. Mercado-Pimentel M.E., Hubbard A.D., Runyan R.B. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev. Biol. 2007, 304:420-432.
120. Miao C.Y., Zuberbuhler J.S., Zuberbuhler J.R. Prevalence of congenital cardiac anomalies at high altitude. J. Am. Coll. Cardiol. 1988, 12:224-228.
121. Miosge N., Sasaki T., Chu M.L., Herken R., Timpl R. Ultrastructural localization of microfibrillar fibulin-1 and fibulin-2 during heart development indicates a switch in molecular associations. Cell Mol. Life Sci. 1998, 54:606-613.
122. Miquerol L., Langille B.L., Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000, 127:3941-3946.
123. Mulholland D.L., Gotlieb A.I. Cell biology of valvular interstitial cells. Can. J. Cardiol. 1996, 12:231-236.
124. Nakamura T., Colbert M., Krenz M., Hahn H., Molkentin J., Robbins J. Rescue of the cardiac phenotype of noonan syndrome in vivo by ablation of cardiac ERK1/2 signaling. Circulation 2006, 114. 7-7.
125. Nasuti J.F., Zhang P.J., Feldman M.D., Pasha T., Khurana J.S., Gorman J.H., Gorman R.C., Narula J., Narula N. Fibrillin and other matrix proteins in mitral valve prolapse syndrome. Ann. Thorac. Surg. 2004, 77:532-536.
126. Nebigil C.G., Maroteaux L. A novel role for serotonin in heart. Trends Cardiovasc. Med. 2001, 11:329-335.
127. Negro A., Brar B.K., Lee K.F. Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog. Horm. Res. 2004, 59:1-12.
128. Ng C.M., Cheng A., Myers L.A., Martinez-Murillo F., Jie C.F., Bedja D., Gabrielson K.L., Hausladen J.M., Mecham R.P., Judge D.P., Dietz H.C. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 2004, 114:1586-1592.
129. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 2008, 182:315-325.
130. Nieto M.A., Sargent M.G., Wilkinson D.G., Cooke J. Control of cell behavior during vertebrate development by slug, a zinc finger gene. Science 1994, 264:835-839.
131. Noble P.W., McKee C.M., Cowman M., Shin H.S. Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J. Exp. Med. 1996, 183:2373-2378.
132. Norris R.A., Kern C.B., Wessels A., Wirrig E.E., Markwald R.R., Mjaatvedt C.H. Detection of beta ig-H3, a TGF beta induced gene, during cardiac development and its complementary pattern with periostin. Anat. Embryol. 2005, 210:13-23.
133. Norris R.A., Damon B., Mironov V., Kasyanov V., Ramamurthi A., Moreno-Rodriguez R., Trusk T., Potts J.D., Goodwin R.L., Davis J., Hoffman S., Wen X., Sugi Y., Kern C.B., Mjaatvedt C.H., Turner D.K., Oka T., Conway S.J., Molkentin J.D., Forgacs G., Markwald R.R. Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J. Cell Biochem. 2007, 101:695-711.
134. Norris R.A., Moreno-Rodriguez R., Sugi Y., Hoffman S., Amos J., Hart M., Potts J.D., Goodwin R.L., Markwald R.R. Periostin regulates atrioventricular valve maturation. Dev. Biol. 2008, 316:200-213.
135. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., Shahidi R., Dorovini-Zis K., Li L.H., Beckstead B., Durand R.E., Hoodless P.A., Karsan A. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ. Res. 2004, 94:910-917.
136. Oka T., Xu J., Kaiser R.A., Melendez J., Hambleton M., Sargent M.A., Lorts A., Brunskill E.W., Gerald W., Dorn I., Conway S.J., Aronow B.J., Robbins J., Molkentin J.D. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ. Res. 2007, 101:313-321.
137. Okagawa H., Markwald R.R., Sugi Y. Functional BMP receptor in endocardial cells is required in atrioventricular cushion mesenchymal cell formation in chick. Dev. Biol. 2007, 306:179-192.
138. Oosthoek P.W., Wenink A.C., Vrolijk B.C., Wisse L.J., DeRuiter M.C., Poelmann R.E., Gittenberger-de Groot A.C. Development of the atrioventricular valve tension apparatus in the human heart. Anat. Embryol. 1998, 198:317-329.
139. Pandit B., Sarkozy A., Pennacchio L.A., Carta C., Oishi K., Martinelli S., Pogna E.A., Schackwitz W., Ustaszewska A., Landstrom A., Bos J.M., Ommen S.R., Esposito G., Lepri F., Faul C., Mundel P., Siguero J.P., Tenconi R., Selicorni A., Rossi C., Mazzanti L., Torrente I., Marino B., Digilio M.C., Zampino G., Ackerman M.J., Dallapiccola B., Tartaglia M., Gelb B.D. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat. Genet. 2007, 39:1007-1012.
140. Paruchuri S., Yang J.H., Aikawa E., Melero-Martin J.M., Khan Z.A., Loukogeorgakis S., Schoen F.J., Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta(2). Circ. Res. 2006, 99:861-869.
141. Patten B.M., Kramer T.C., Barry A. Valvular action in the embryonic chick heart by localized apposition of endocardial masses. Anat. Rec. 1948, 102:299-311.
142. Pierpont M.E., Basson C.T., Benson W.D., Gelb B.D., Giglia T.M., Goldmuntz E., McGee G., Sable C.A., Srivastava D., Webb C.L. Genetic basis for congenital heart defects: Current knowledge. Circulation 2007, 115:3015-3038.
143. Poelmann R.E., Lie-Venema H., Gittenberger-de Groot A.C. The role of the epicardium and neural crest. Tex. Heart Inst. J. 2002, 29:255-261.
144. Porter G.A., Makuck R.F, Rivkees S.A. Intracellular calcium plays an essential role in cardiac development. Dev. Dyn. 2003, 227:280-290.
145. Portin P. General outlines of the molecular genetics of the Notch signaling pathway in Drosophila melanogaster, a review. Hereditas 2002, 136:89-96.
146. Potts J.D., Runyan R.B. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. Dev. Biol. 1989, 134:392-401.
147. Potts J.D., Dagle J.M., Walder J.A., Weeks D.L., Runyan R.B. Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor beta 3. Proc. Nat. Acad. Sci. U.S.A. 1991, 88:1516-1520.
148. Potts J.D., Vincent E.B., Runyan R.B., Weeks D.L. Sense and antisense TGF beta 3 mRNA levels correlate with cardiac valve induction. Dev. Dyn. 1992, 193(4):340-345.
149. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392:186-190.
150. Razzaque M.A., Nishizawa T., Komoike Y., Yagi H., Furutani M., Amo R., Kamisago M., Momma K., Katayama H., Nakagawa M., Fujiwara Y., Matsushima M., Mizuno K., Tokuyama M., Hirota H., Muneuchi J., Higashinakagawa T., Matsuoka R. Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat. Genet. 2007, 39:1013-1017.
151. Ritz B., Yu F., Fruin S., Chapa G., Shaw G.M., Harris J.A. Ambient air pollution and risk of birth defects in Southern California. Am. J. Epidemiol. 2002, 155:17-25.
152. Rivera-Feliciano J., Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 2006, 295:580-588.
153. Roberts A.B., Tian F., Byfield S.D., Stuelten C., Ooshima A., Saika S., Flanders K.C. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 2006, 17:19-27.
154. Rodgers L.S., Lalani S., Hardy K.M., Xiang X.Y., Broka D., Antin P.B., Camenisch T.D. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ. Res. 2006, 99:583-589.
155. Romano L.A., Runyan R.B. Slug is a mediator of epithelial-mesenchymal cell transformation in the developing chicken heart. Dev. Biol. 1999, 212:243-254.
156. Romano L.A., Runyan R.B. Slug is an essential target of TGF beta 2 signaling in the developing chicken heart. Dev. Biol. 2000, 223:91-102.
157. Runyan R.B., Markwald R.R. Invasion of mesenchyme into three dimensional collagen gels: A regional and temporal analysis of interaction in heart tissue. Dev. Biol. 1983, 95:108-114.
158. Runyan R.B., Potts J.D., Weeks D.L., Sharma R.V., Loeber C.L., Chiang J.J., Bhalla R.C. Tissue interaction and signal transduction in the atrioventricular-canal of the embryonic heart. Ann. N.Y. Acad. Sci. 1990, 588:442-443.
159. Runyan R.B., Potts J.D., Weeks D.L. TGF-beta 3-mediated tissue interaction during embryonic heart development. Mol. Repro. Dev. 1992, 32:152-159.
160. Sakabe M., Ikeda K., Nakatani K., Kawada N., Imanaka-Yoshida K., Yoshida T., Yamagishi T., Nakajima Y. Rho kinases regulate endothelial invasion and migration during valvuloseptal endocardial cushion tissue formation. Dev. Dyn. 2006, 235:94-104.
161. Sakata Y., Koibuchi N., Xiang F., Youngblood J.M., Kamei C.N., Chin M.T. The spectrum of cardiovascular anomalies in CHF1/Hey2 deficient mice reveals roles in endocardial cushion, myocardial and vascular maturation. J. Mol. Cell Cardiol. 2006, 40:267-273.
162. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFß2 knockout mice have multiple development defects that are non-overlapping with other TGFß knockout phenotypes. Development 1997, 124:2659-2670.
163. Schubbert S., Zenker M., Rowe S.L., Boll S., Klein C., Bollag G., van der Burgt I., Musante L., Kalscheuer V., Wehner L.E., Nguyen H., West B., Zhang K.Y., Sistermans E., Rauch A., Niemeyer C.M., Shannon K., Kratz C.P. Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 2006, 38:331-336.
164. Sedmera D., Hu N., Weiss K.M., Keller B.B., Denslow S., Thompson R.P. Cellular changes in experimental left heart hypoplasia. Anat. Rec. 2002, 267:137-145.
165. Sheffield V.C., Pierpont M.E., Nishimura D., Beck J.S., Burns T.L., Berg M.A., Stone E.M., Patil S.R., Lauer R.M. Identification of a complex congenital heart defect susceptibility locus by using DNA pooling and shared segment analysis. Hum. Mol. Genet. 1997, 6:117-121.
166. Sheng W., Wang G.Z., Wang Y.L., Liang J.Y., Wen J.P., Zheng P.S., Wu Y.J., Lee V., Slingerland J., Dumont D., Yang B.B. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 2005, 16:1330-1340.
167. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
168. Sinning A.R., Lepera R.C., Markwald R.R. Initial expression of type I procollagen in chick cardiac mesenchyme is dependent upon myocardial stimulation. Dev. Biol. 1988, 130(1):167-174.
169. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtosos C., Cheung A., Hahn S., Wakehem A., Schartz L., Kern S.E., Rossant J., Mak T.W. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 1998, 12:107-119.
170. Slevin M., Krupinski J., Kumar S., Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab. Invest. 1998, 78:987-1003.
171. Snider P., Hinton R.B., Moreno-Rodriguez R.A., Wang J., Rogers R., Lindsley A., Li F., Ingram D.A., Menick D., Field L., Firulli A.B., Molkentin J.D., Markwald R., Conway S.J. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ. Res. 2008, 102(7):752-760.
172. Somi S., Buffing A.A., Moorman A.F., Van Den Hoff M.J. Dynamic patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart development. Anat. Rec. (Part A: Discoveries in Mol. Cellular and Evol. Biol.) 2004, 279A:636-651.
173. Song W.M., Jackson K., McGuire P.G. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev. Biol. 2000, 227:606-617.
174. Sorensen L.K., Brooke B.S., Li D.Y., Urness L.D. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGF beta coreceptor. Dev. Biol. 2003, 261:235-250.
175. Stevens M.V., Parker P., Vaillancourt R.R., Camenisch T.D. MEKK4 regulates developmental EMT in the embryonic heart. Dev. Dyn. 2006, 235:2761-2770.
176. 2-dependent epithelial-to-mesenchymal transition during endocardial cushion morphogenesis. Circ. Res. 2008, 103:1430-1440.
177. Sugi Y., Ito N., Szebenyi G., Myers K., Fallon J.F., Mikawa T., Markwald R.R. Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation. Dev. Biol. 2003, 258:252-263.
178. Sugi Y., Yamamura H., Okagawa H., Markwald R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 2004, 269:505-518.
179. Sun Y.P., Lowther W., Kato K., Bianco C., Kenney N., Strizzi L., Raafat D., Hirota M., Khan N.I., Bargo S., Jones B., Salomon D., Callahan R. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling. Oncogene 2005, 24:5365-5374.
180. Tavares A.L., Mercado-Pimentel M.E., Runyan R.B., Kitten G.T. TGF-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev. Dyn. 2006, 235:1589-1598.
181. Taylor P.A., Batten P., Brand N.J., Thomas P.S., Yacoub M.H. The cardiac valve interstitial cell. Int. J. Biochem. Cell Biol. 2003, 35:113-118.
182. Tendijke P., Yamashita H., Ichijo H., Franzen P., Laiho M., Miyazono K., Heldin C.H. Characterization of type-I receptors for transforming growth-factor-beta and activin. Science 1994, 264:101-104.
183. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., Aranda S., Palomo S., McCormick F., Izpisua-Belmonte J.C., de la Pompa J.L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
184. Tkatchenko A., Tkatchenko T., Moreno-Rodriguez R., Markwald R. Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol. Genom. 2009, 39:160-168.
185. Varadkar P., Kraman M., Despres D., Ma G., Lozier J., McCright B. Notch2 is required for the proliferation of cardiac neural crest-derived smooth muscle cells. Dev. Dyn. 2008, 237:1144-1152.
186. Visconti R.P., Ebihara Y., LaRue A.C., Fleming P.A., McQuinn T.C., Masuya M., Minamiguchi H., Markwald R.R., Ogawa M., Drake C.J. An in vivo analysis of hematopoietic stem cell potential - Hematopoietic origin of cardiac valve interstitial cells. Circ. Res. 2006, 98:690-696.
187. Wall N.A, Hogan B.L. Expression of bone morphogenetic protein-4 (bmp-4), bone morphogenetic protein-7 (bmp-7), fibroblast growth factor-VIII (fgf-8) and sonic hedgehog (shh) during branchial arch development in the chick. Mech. Dev. 1995, 53:383-392.
188. Walsh E.C., Stainier D.Y. Udp-glucose dehydrogenase required for cardiac valve formation in zebrafish. Science 2001, 293:1670-1673.
189. Wang J., Sridurongrit S., Dudas M., Thomas P., Nagy A., Schneider M.D., Epstein J.A., Kaartinen V. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev. Biol. 2005, 286:299-310.
190. Wang X., Merritt A.J., Seyfried J., Guo C., Papadakis E.S., Finegan K.G., Kayahara M., Dixon J., Boot-Handford R.P., Cartwright E.J., Mayer U., Tournier C. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol. Cell Biol. 2005, 25:336-345.
191. Watanabe Y., Kokubo H., Miyagawa-Tomita S., Endo M., Igarashi K., Aisaki K., Kanno J., Saga Y. Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse. Development 2006, 133:1625-1634.
192. Webb S., Anderson R.H., Brown N.A. Endocardial cushion development and heart loop architecture in the trisomy 16 mouse. Dev. Dyn. 1996, 206:301-309.
193. Webb S., Brown N.A., Anderson R.H. Formation of the atrioventricular septal structures in the normal mouse. Circ. Res. 1998, 82:645-656.
194. Wessels A., Markman M.W., Vermeulen J.L., Anderson R.H., Moorman A.F., Lamers W.H. The development of the atrioventricular junction in the human heart. Circ. Res. 1996, 78:110-117.
195. Winnier G.E., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 1995, 9:2105-2116.
196. Winnier G.E., Kume T., Deng K.Y., Rogers R., Bundy J., Raines C., Walter M.A., Hogan B.L., Conway S.J. Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonallelic noncomplementation of null alleles. Dev. Biol. 1999, 213:418-431.
197. Wrana J.L., Attisano L., Wieser R., Ventura F., Massagué J. Mechanism of activation of the TGF-b receptor. Nature 1994, 370:341-347.
198. Wunsch A.M., Little C.D., Markwald R.R. Cardiac endothelial heterogeneity defines valvular development as demonstrated by the diverse expression of Jb3, an antigen of the endocardial cushion tissue. Dev. Biol. 1994, 165:585-601.
199. Yamada M., Szendro P.I., Prokscha A., Schwartz R.J., Eichele G. Evidence for a role of Smad6 in chick cardiac development. Dev. Biol. 1999, 215:48-61.
200. Yamagishi T., Nakajima Y., Miyazono K., Nakamura H. Bone morphogenetic protein-2 acts synergistically with transforming growth factor-beta 3 during endothelial-mesenchymal transformation in the developing chick heart. J. Cell Physiol. 1999, 180:35-45.
201. Yamashita H., TenDijke P., Heldin C.H., Miyazono K. Bone morphogenetic protein receptors. Bone 1996, 19:569-574.
202. Yang X.B., Tare R.S., Partridge K.A., Roach H.I., Clarke N.M., Howdle S.M., Shakesheff K.M., Oreffo R.O. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin, Osteoconductive biomimetic scaffolds for tissue engineering. J. Bone Min. Res. 2003, 18:47-57.
203. Yarden Y., Sliwkowski M.X. Untangling the ErbB signaling network. Nat. Rev. Mol. Cell Biol. 2001, 2:127-137.
204. Yi S.E., Daluiski A., Pederson R., Rosen V., Lyons K.M. The type IBMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 2000, 127:621-630.
205. Zhang H.B., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion chorion and cardiac development. Development 1996, 122:2977-2986.
206. Zhang N., Mustin D., Reardon W., DeAlmeida A., Mozdziak P., Mrug M., Eisenberg L.M., Sedmera D. Blood-borne stem cells differentiate into vascular and cardiac lineages during normal development. Stem Cells Dev. 2006, 15:17-28.